跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Redoxon Immunity blackcurrant effervescent tablets - TGA Drug Approval Details
Approvals
/
TGA
/
Redoxon Immunity blackcurrant effervescent tablets
Approved
STANDARD
Redoxon Immunity blackcurrant effervescent tablets
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
afc8df9d6e01321a
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
afc8df9d6e01321a
Product Name
Redoxon Immunity blackcurrant effervescent tablets
Artg Id
340854
Artg Name
Redoxon Immunity blackcurrant effervescent tablets
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2020-08-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
afc8df9d6e01321a
Type
Standard
Back to TGA Approvals
